Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
St. Erik Eye Hospital
The Swedish Society of Medicine (SLS-971390)
The Royal Swedish Academy of Sciences (ME2019-0036)
Cancerfonden (20 0798 Fk)
Region Stockholm (RS-2019-1138)
The Swedish Eye Foundation (2022-05-02)
Karolinska Institutet (FS-2021-0010)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 13 March 2023
First Online: 26 March 2023
Declarations
:
: The trial is going to be performed according to the trial protocol, CTR regarding human medicine (536/2014), Helsinki Declaration, ICH-GCP, and the current national regulation relevant to this clinical trial. EU-trial number: 2022–500307-49–00. The trial is approved by The Swedish Medical Products Agency and The Swedish Ethical Review Authority.Signed informed consent forms will be obtained from all trial participants (see the “ ” section for more information).
: Not applicable.
: The authors declare that they have no competing interests.
